APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 40 filers reported holding APTEVO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $567,000 | +10.7% | 866,778 | -0.4% | 0.00% | – |
| Q3 2019 | $512,000 | -48.5% | 870,628 | -22.4% | 0.00% | – |
| Q2 2019 | $994,000 | -25.7% | 1,122,138 | -24.5% | 0.00% | – |
| Q1 2019 | $1,337,000 | +44.1% | 1,486,565 | +103.6% | 0.00% | – |
| Q4 2018 | $928,000 | -75.1% | 730,296 | -0.4% | 0.00% | – |
| Q3 2018 | $3,725,000 | +1.8% | 733,211 | 0.0% | 0.00% | – |
| Q2 2018 | $3,659,000 | +51.4% | 733,211 | -0.8% | 0.00% | – |
| Q1 2018 | $2,416,000 | -23.0% | 738,849 | -0.2% | 0.00% | – |
| Q4 2017 | $3,137,000 | +95.1% | 739,987 | +5.4% | 0.00% | – |
| Q3 2017 | $1,608,000 | +10.6% | 702,375 | +0.0% | 0.00% | – |
| Q2 2017 | $1,454,000 | -7.8% | 702,146 | -8.3% | 0.00% | – |
| Q1 2017 | $1,577,000 | -24.6% | 765,771 | -10.7% | 0.00% | – |
| Q4 2016 | $2,092,000 | -2.3% | 857,367 | +2.5% | 0.00% | – |
| Q3 2016 | $2,142,000 | – | 836,593 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 974,492 | $2,495,000 | 0.55% |
| Perceptive Advisors | 988,133 | $2,530,000 | 0.16% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 38,860 | $99,000 | 0.07% |
| Laurel Wealth Advisors, Inc. | 42,890 | $110,000 | 0.05% |
| CSS LLC/IL | 353,977 | $906,000 | 0.04% |
| GLG Partners LP | 396,486 | $1,015,000 | 0.03% |
| Capital Impact Advisors, LLC | 12,318 | $32,000 | 0.01% |
| Spark Investment Management LLC | 66,000 | $168,000 | 0.01% |
| Peak Asset Management, LLC | 10,000 | $26,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 99,390 | $254,000 | 0.01% |